These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 12325040

  • 1. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
    Blackburn TP, Minabe Y, Middlemiss DN, Shirayama Y, Hashimoto K, Ashby CR.
    Synapse; 2002 Dec 01; 46(3):129-39. PubMed ID: 12325040
    [Abstract] [Full Text] [Related]

  • 2. Effect of the acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y, Shirayama Y, Hashimoto K, Routledge C, Hagan JJ, Ashby CR.
    Synapse; 2004 Apr 01; 52(1):20-8. PubMed ID: 14755629
    [Abstract] [Full Text] [Related]

  • 3. The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study.
    Blackburn TP, Suzuki K, Ashby CR.
    Synapse; 2006 Jun 15; 59(8):502-12. PubMed ID: 16565966
    [Abstract] [Full Text] [Related]

  • 4. Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study.
    Minabe Y, Hashimoto K, Watanabe KI, Ashby CR.
    Synapse; 2001 May 15; 40(2):102-12. PubMed ID: 11252021
    [Abstract] [Full Text] [Related]

  • 5. The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study.
    Minabe Y, Emori K, Toor A, Stutzmann GE, Ashby CR.
    Synapse; 1996 Jan 15; 22(1):35-45. PubMed ID: 8822476
    [Abstract] [Full Text] [Related]

  • 6. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Nakamura K, Suzuki K, McCreary AC, Ashby CR.
    Synapse; 2006 May 15; 59(6):359-67. PubMed ID: 16463399
    [Abstract] [Full Text] [Related]

  • 7. Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study.
    Minabe Y, Matsuno K, Ashby CR.
    Synapse; 1999 Aug 15; 33(2):129-40. PubMed ID: 10400891
    [Abstract] [Full Text] [Related]

  • 8. Effect of the acute and chronic administration of the selective neurokinin2 receptor antagonist SR 48968 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
    Minabe Y, Ashby CR.
    Synapse; 1997 Feb 15; 25(2):196-204. PubMed ID: 9021900
    [Abstract] [Full Text] [Related]

  • 9. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Ashby CR, Minabe Y, Stemp G, Hagan JJ, Middlemiss DN.
    J Pharmacol Exp Ther; 2000 Sep 15; 294(3):1166-74. PubMed ID: 10945873
    [Abstract] [Full Text] [Related]

  • 10. SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system.
    Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E.
    Neuropharmacology; 1999 Aug 15; 38(8):1195-205. PubMed ID: 10462132
    [Abstract] [Full Text] [Related]

  • 11. Stimulation of serotonin2C receptors blocks the hyperactivation of midbrain dopamine neurons induced by nicotine administration.
    Pierucci M, Di Matteo V, Esposito E.
    J Pharmacol Exp Ther; 2004 Apr 15; 309(1):109-18. PubMed ID: 14722316
    [Abstract] [Full Text] [Related]

  • 12. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y, Schechter L, Hashimoto K, Shirayama Y, Ashby CR.
    Synapse; 2003 Dec 01; 50(3):181-90. PubMed ID: 14515335
    [Abstract] [Full Text] [Related]

  • 13. Effect of the acute and chronic administration of the putative atypical antipsychotic drug Y-931 (8-fluoro-12- (4-methylpiperazin-1-yl)-6H-[1]benzothieno[2,3b][1,5] benzodiazepine maleate) on spontaneously active rat midbrain dopamine neurons: an in vivo electrophysiological study.
    Minabe Y, Hashimoto K, Shirayama Y, Ashby CR.
    Synapse; 2004 Jan 01; 51(1):19-26. PubMed ID: 14579422
    [Abstract] [Full Text] [Related]

  • 14. Intracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide significantly alters the activity of ventral tegmental area dopamine neurons: an electrophysiological study.
    Tajiri K, Emori K, Murata M, Tanaka K, Suzuki M, Uehara T, Sumiyoshi T, Ashby CR, Kurachi M.
    Synapse; 2001 Jun 15; 40(4):275-81. PubMed ID: 11309843
    [Abstract] [Full Text] [Related]

  • 15. Chronic treatment with DAU 6215, a new 5-HT3 receptor antagonist, causes a selective decrease in the number of spontaneously active dopaminergic neurons in the rat ventral tegmental area.
    Prisco S, Pessia M, Ceci A, Borsini F, Esposito E.
    Eur J Pharmacol; 1992 Apr 07; 214(1):13-9. PubMed ID: 1582449
    [Abstract] [Full Text] [Related]

  • 16. The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study.
    Minabe Y, Emori K, Ashby CR.
    Synapse; 1996 Jan 07; 22(1):46-53. PubMed ID: 8822477
    [Abstract] [Full Text] [Related]

  • 17. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.
    Skarsfeldt T.
    Synapse; 1992 Jan 07; 10(1):25-33. PubMed ID: 1346943
    [Abstract] [Full Text] [Related]

  • 18. The novel atypical antipsychotic cariprazine demonstrates dopamine D2 receptor-dependent partial agonist actions on rat mesencephalic dopamine neuronal activity.
    Delcourte S, Ashby CR, Rovera R, Kiss B, Adham N, Farkas B, Haddjeri N.
    CNS Neurosci Ther; 2018 Dec 07; 24(12):1129-1139. PubMed ID: 29729086
    [Abstract] [Full Text] [Related]

  • 19. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G, Di Matteo V, Di Mascio M, Esposito E.
    Synapse; 2000 Jan 07; 35(1):53-61. PubMed ID: 10579808
    [Abstract] [Full Text] [Related]

  • 20. Effects of acute and repeated administration of amisulpride, a dopamine D2/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons.
    Di Giovanni G, Di Mascio M, Di Matteo V, Esposito E.
    J Pharmacol Exp Ther; 1998 Oct 07; 287(1):51-7. PubMed ID: 9765321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.